• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Study on rapid diagnosis and B cell defect of X-linked agammaglobulinemia

Research Project

Project/Area Number 10470176
Research Category

Grant-in-Aid for Scientific Research (B)

Allocation TypeSingle-year Grants
Section一般
Research Field Pediatrics
Research InstitutionToyama Medical and Pharmaceutical University

Principal Investigator

MIYAWAKI Toshio  Toyama Medical & Pharmaceutical University Faculty of Medicine Professor, 医学部, 教授 (10143885)

Co-Investigator(Kenkyū-buntansha) KANEGANE Hirokazu  Toyama Medical & Pharmaceutical University University Hospital Research Asociate, 附属病院, 助手 (00293324)
Project Period (FY) 1998 – 1999
Project Status Completed (Fiscal Year 1999)
Budget Amount *help
¥13,100,000 (Direct Cost: ¥13,100,000)
Fiscal Year 1999: ¥1,700,000 (Direct Cost: ¥1,700,000)
Fiscal Year 1998: ¥11,400,000 (Direct Cost: ¥11,400,000)
Keywordsimmunodeficiency / agammaglobulinemia / XLA / Btk / flow cytometory / B cells / pro-B cells / B cell defect / 単球 / モノカイン
Research Abstract

X-linked agammaglobulinemia (XLA), a relatively common immunodeficieny disorder, is characterized by the paucity of peripheral blood B cells, markedly reduced levels of serum immunoglobulins, and the occurrence of severe bacterial infection during the early period of infancy. In 1993, the causative gene for XLA has been identified as Bruton's tyrosine kinase (Btk), which plays a pivotal role in B cell activation and early B cell differentiation. The detection of XLA patients and carriers has been performed by demonstration of Btk mutations internationally. In the present study, we developed the clinically useful and simple method for identification of XLA and its carrier, searched for the distribution of XLA in Japan by the combined use with Btk genetic analysis, and elucidated clinical variability of XLA. In addition, we attempted to learn some of the pathogenic significance of Btk in XLA. The results obtained here are as follows :
1) Employing Btk expression in monocytes, we showed th … More at a flow cytometric analysis using anti-Btk monoclonal antibody could detect easily and rapidly XLA and its carrier.
2) By the use of both flow cytometric and genetic analyses, we newly identified 65 cases with XLA, resulting in our confirmation of totally 100 families with XLA in Japan.
3) Atypical cases with XLA, who showed the normal range of serum IgG or the adult onset, were discovered.
4) Investigation of Japanese Immunodeficiency Registry presented the possibility that a number of XLA cases without family history often misdiagnosed as CVID.
5) Examination of bone marrow from XLA using anti-VpreB monoclonal antibody for the first time demonstrated that the genetic defect in XLA might impede the maturational evolution of pro-B cells into the later stage of pre-B cells in B cell differentiation pathway.
6) It was demonstrated that neutropenia was occasionally associated with XLA, and Btk was possibly involved for the essential function of monocytes/macrophages in neutropoiesis through production of some cytokines. Less

Report

(3 results)
  • 1999 Annual Research Report   Final Research Report Summary
  • 1998 Annual Research Report
  • Research Products

    (24 results)

All Other

All Publications (24 results)

  • [Publications] Futatani T. et al.: "Deficient expression of Brutons's tyrosine kinase in monocytes from X-linked agammaglobulinemia as evaluated by a flow cytometric analysis and its clinical application to carrier detection"Blood. 91. 595-602 (1998)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Nonoyama S. et al.: "Functional analysis of peripheral blood B cells in patients with X-linked agammaglobulinemia"Journal of Immunology. 161. 3925-3929 (1998)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Hashimoto S. et al.: "A typical X-linked agammaglobulinemia diagnosed in three adults"Internal Medicine. 38. 722-725 (1999)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Kanegane H. et al.: "X-linked thrombocytopenia identified by a flow cytometric demonstration of defective Wiskott-Aldrich syndrome protein in lymphocytes"Blood. 95. 1110-1111 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Nomura K. et al.: "The genetic defect in human X-linked agammaglobulinemia impedes a maturational evolution of pro-B cells into later stage of pre-B cells in B cell differentiation pathway"Blood. (In press).

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Kanegane H. et al.: "Detection of Bruton's tyrosine kinase mutations in hypogammaglobulinemic males registered as common variable immunodeficiency in the Japanese Immunodeficiency Registry"Clinical and Experimental Immunology. (In press).

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Futatani T. et al.: "Deficient expression of Bruton's tyrosine kinase in monocytes from X-linked agammaglobulinemia as evaluated by a flow cytometric analysis and its clinical application to carrier detection"Blood. 91. 595-602 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Nonoyama S. et al.: "Functional analysis of peripheral blood B cells in patients with X-linked agammaglobulinemia"Journal of Immunology. 161. 3925-3929 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Hashimoto S. et al.: "A typical X-linked agammaglobulinemia diagnosed in three adults"Internal Medicine. 38. 722-725 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Kanegane H. et al.: "X-linked thrombocytopenia identified by a flow cytometric demonstration of defective Wiskott-Aldrich syndrome protein in lymphocytes"Blood. 95. 1110-1111 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Nomura K. et al.: "The genetic defect in human X-linked agammaglobulinemia impedes a maturational evolution of pro-B cells into later stage of pre-B cells in B cell differentiation pathway"Blood. (in press).

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Kanegane H. et al.: "Detection of Bruton's tyrosine kinase mutations in hypogammaglobulinemic males registered as common variable immunodeficiency in the Japanese Immunodeficiency Registry"Clinical and Experimental Immunology. (in press).

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Kanegane H. et al.: "Development of EBV-positive T-cell lymphoma following infection of peripheral blood T cells with EBV"Lymphoma and Leukemia. 34:5-6. 603-607 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] Hashimoto S. et al.: "Atypical X-linked agammaglobulinemia diagnosed in three adults"Internal Medicine. 38:9. 722-725 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] Kanegane H. et al.: "X-linked thrombocytopenia identified by flow cytometric demonstration of defective Wiskott-Aldrich syndrome protein in lymphocytes"Blood. 95:3. 1110-1111 (2000)

    • Related Report
      1999 Annual Research Report
  • [Publications] Kanegane H. et al.: "Detection of Bruton's tyrosine kinase mutations in hypogammaglobulinemic males registered as common variable immunodeficiency in the Japan Immunodeficiency Registry"Clinical and Experimental Immunology. (In Press).

    • Related Report
      1999 Annual Research Report
  • [Publications] Honda K. et al.: "Large deletion of the X-linked lymphoproliferative gene detected by fluorescence in situ hybridization"American Journal of Hematology. (In press).

    • Related Report
      1999 Annual Research Report
  • [Publications] Nomura K. et al.: "The genetic defect in human X-linked agammaglobulinemia impedes a maturational evolution of pro-B cells into later stage of pre-B cells in B cell differentiation pathway"Blood. (In press).

    • Related Report
      1999 Annual Research Report
  • [Publications] Futatani T.et al.: "Deficient expression of Bruton's Tyrosine Kinase in monocytes from X-Linked agammaglobulinemia as evaluated by a flow cytometric analysis and its clinical application to carrier detection." Blood. 91. 595-602 (1998)

    • Related Report
      1998 Annual Research Report
  • [Publications] Kasahara Y.et al.: "Novel Fas(CD95/AP0-1)mutations in infants with a lymphoproliferative disorder." International Immuno.10. 195-202 (1998)

    • Related Report
      1998 Annual Research Report
  • [Publications] Kanegane H.et al.: "EBV-NK cells interactions and lymphoproliferative disorders." Leuk.and Lymph.29. 491-498 (1998)

    • Related Report
      1998 Annual Research Report
  • [Publications] Morikawa K.et al.: "Deoxyspergualin preferentially inhibits the growth and maturation of anti-CD40-activated surface IgD+B lymphocytes." Clin.Exp.Immunol.112. 495-500 (1998)

    • Related Report
      1998 Annual Research Report
  • [Publications] Wada T.et al.: "Developmental changes and functional properties of human memory T cell subpopulations defined by CD60 expression." Cell.Immunol.187. 117-123 (1998)

    • Related Report
      1998 Annual Research Report
  • [Publications] Hongou K.et al.: "Rotavirus encephalitis mimicking afebrile benign convulsions in infants." Pediatr Neurol.18. 354-357 (1998)

    • Related Report
      1998 Annual Research Report

URL: 

Published: 1998-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi